A biotechnology company focusing on the development of food allergies received $1.9 million in funding for preclinical studies and product development, enabling preparations for a…
The Arkansas Children’s Research Institute, located on the campus of Arkansas Children’s Hospital, spent 18 years working on the drug Palforzia, recently approved by the U.S.…
Stacie M. Jones, M.D., is Professor and Chief of Allergy and Immunology at the University of Arkansas for Medical Sciences (UAMS) and Arkansas Children’s Hospital…
Aimmune announced the U.S. FDA has approved Palforzia [Peanut (Arachis hypogaea) Allergen Powder-dnfp], making this the first approved treatment for patients with a confirmed diagnosis…
The U.S. Food and Drug Administration approved Aimmune Therapeutics’ Palforzia [Peanut (Arachis hypogaea) Allergen Powder-dnfp] to mitigate allergic reactions, including anaphylaxis, that may occur with accidental exposure to…
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.
